Reuters logo
BRIEF-Biofrontera: EMA recommends indication expansion of ameluz for treatment of basal cell carcinoma
December 20, 2016 / 3:35 PM / a year ago

BRIEF-Biofrontera: EMA recommends indication expansion of ameluz for treatment of basal cell carcinoma

Dec 20 (Reuters) - Biofrontera AG :

* European Medicines Agency recommends indication expansion of ameluz for treatment of basal cell carcinoma

* Approval by European Commission expected in next few weeks Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below